Malic enzyme 2 promotes the progression of hepatocellular carcinoma via increasing triglyceride production.
Cancer Med
; 10(19): 6795-6806, 2021 10.
Article
em En
| MEDLINE
| ID: mdl-34427987
ABSTRACT
The incidence and mortality of hepatocellular carcinoma (HCC) are gradually increasing during the past years. Recently, some studies have reported that malic enzyme (ME) plays an important role in cancer development, while the involvement of ME2 in HCC remains still undetermined. Here, we demonstrated that ME2 played an oncogenic role in HCC. ME2 was overexpressed in HCC tissues. TCGA database showed that the ME2 transcript level was inversely associated with the survival of HCC patients. Loss-of-function and gain-of-function assays showed that ME2 promoted HCC cell growth and migration. Furthermore, the xenografted tumorigenesis of MHCC97H cells was retarded by ME2 knockdown. ME2 silencing also suppressed the cell cycle process and induced apoptosis. Mechanistically, ME2 potentiated triglyceride synthesis, inhibition of which suppressed the proliferation and migration. We propose that ME2 promotes HCC progression by increasing triglyceride production.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Triglicerídeos
/
Carcinoma Hepatocelular
/
Neoplasias Hepáticas
/
Malato Desidrogenase
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article